{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T04:53:25Z","timestamp":1751604805335},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T00:00:00Z","timestamp":1492041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002426","name":"Telethon","doi-asserted-by":"publisher","award":["GGP14066"],"award-info":[{"award-number":["GGP14066"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK56598"],"award-info":[{"award-number":["DK56598"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009881","name":"Regione Liguria","doi-asserted-by":"crossref","award":["FAS 2013"],"award-info":[{"award-number":["FAS 2013"]}],"id":[{"id":"10.13039\/501100009881","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.ymgme.2017.03.009","type":"journal-article","created":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T17:47:26Z","timestamp":1491241646000},"page":"28-34","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Generation of induced Pluripotent Stem Cells as disease modelling of NLSDM"],"prefix":"10.1016","volume":"121","author":[{"given":"D.","family":"Tavian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Missaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Castagnetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Degiorgio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.M.","family":"Pennisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.A.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Dell'Era","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Mora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Angelini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.A.","family":"Coviello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2017.03.009_bb0005","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/ng1951","article-title":"The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy","volume":"39","author":"Fischer","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2017.03.009_bb0010","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bbrc.2008.10.081","article-title":"Novel mutations in the adipose triglyceride lipase gene causing neutral lipid storage disease with myopathy","volume":"377","author":"Campagna","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2017.03.009_bb0015","doi-asserted-by":"crossref","first-page":"5318","DOI":"10.1093\/hmg\/dds388","article-title":"Contribution of novel ATGL missense mutations to the clinical phenotype of NLSD-M: a strikingly low amount of lipase activity may preserve cardiac function","volume":"21","author":"Tavian","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2017.03.009_bb0020","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/mus.24477","article-title":"A myopathy with unusual features caused by PNPLA2 gene mutations","volume":"51","author":"Pennisi","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2017.03.009_bb0025","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.nmd.2014.04.001","article-title":"A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review","volume":"24","author":"Kaneko","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2017.03.009_bb0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijcard.2016.01.137","article-title":"Severe cardiomyopathy in a young patient with complete deficiency of adipose triglyceride lipase due to a novel mutation in PNPLA2 gene","volume":"207","author":"Pasanisi","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ymgme.2017.03.009_bb0035","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1056\/NEJMc0805305","article-title":"Triglyceride deposit cardiomyovasculopathy","volume":"359","author":"Hirano","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2017.03.009_bb0040","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ymgme.2015.05.001","article-title":"Novel missense mutations in PNPLA2 causing late onset and clinical heterogeneity of neutral lipid storage disease with myopathy in three siblings","volume":"115","author":"Missaglia","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2017.03.009_bb0045","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/jcp.2006.044917","article-title":"Improved cytochemical method for detecting Jordans' bodies in neutral-lipid storage diseases","volume":"60","author":"Tavian","year":"2007","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.ymgme.2017.03.009_bb0050","first-page":"198","article-title":"A late-onset case of neutral lipid storage disease with myopathy, dropped head syndrome, and peripheral nerve involvement","volume":"4","author":"Tavian","year":"2013","journal-title":"J. Genet. Syndr. Gene Ther."},{"key":"10.1016\/j.ymgme.2017.03.009_bb0055","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s00415-011-6055-4","article-title":"The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene","volume":"258","author":"Reilich","year":"2011","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2017.03.009_bb0060","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.bbrc.2013.12.003","article-title":"Genetic mutations in the adipose triglyceride lipase and myocardial overexpression of peroxisome proliferated activated receptor- in patients with triglyceride deposit cardiomyovasculopathy","volume":"443","author":"Hirano","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2017.03.009_bb0065","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bbrc.2012.10.127","article-title":"Subclinical myopathy in a child with neutral lipid storage disease and mutations in the PNPLA2 gene","volume":"430","author":"Fiorillo","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2017.03.009_bb0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijcard.2015.05.004","article-title":"Distinct cardiac phenotype between two homozygotes born in a village with accumulation of a genetic deficiency of adipose triglyceride lipase","volume":"192","author":"Higashi","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ymgme.2017.03.009_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2017.01.011","article-title":"Late onset of neutral lipid storage disease due to novel PNPLA2 mutations totally abrogating lipase activity in a patient with myopathy and slight cardiac involvement","author":"Missaglia","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2017.03.009_bb0080","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ymgme.2017.03.009_bb0085","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.stem.2009.11.009","article-title":"Technical challenges in using human induced pluripotent stem cells to model disease","volume":"5","author":"Saha","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymgme.2017.03.009_bb0090","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nm.3545","article-title":"Modeling the mitochondrial cardiomyopathy of Barth syndrome with iPSC and heart-on-chip technologies","volume":"20","author":"Wang","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymgme.2017.03.009_bb0095","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/stem.2112","article-title":"Concise review: patient-derived stem cell research for monogenic disorders","volume":"34","author":"Qin","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.ymgme.2017.03.009_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119617","article-title":"Reprogramming of HUVECs into induced pluripotent stem cells (HiPSCs), generation and characterization of HiPSC-derived neurons and astrocytes","volume":"10","author":"Haile","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2017.03.009_bb0105","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4252\/wjsc.v8.i4.118","article-title":"Human induced pluripotent stem cells for monogenic disease modelling and therapy","volume":"8","author":"Spitalieri","year":"2016","journal-title":"World J. Stem Cells."},{"key":"10.1016\/j.ymgme.2017.03.009_bb0110","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/scrt125","article-title":"Induced pluripotent stem cell technology for disease modeling and drug screening with emphasis on lysosomal storage diseases","volume":"3","author":"Huang","year":"2012","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ymgme.2017.03.009_bb0115","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003985","article-title":"Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease","volume":"4","author":"Cooper","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgme.2017.03.009_bb0120","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nrm.2015.27","article-title":"Pluripotent stem cells in disease modelling and drug discovery","volume":"17","author":"Avior","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymgme.2017.03.009_bb0125","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s12265-012-9413-4","article-title":"iPS cell modeling of cardiometabolic diseases","volume":"6","author":"Nakamura","year":"2013","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.ymgme.2017.03.009_bb0130","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/hmg\/dds471","article-title":"Neuronopathic Gaucher's disease: induced pluripotent stem cells for disease modelling and testing chaperone activity of small compounds","volume":"22","author":"Tiscornia","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2017.03.009_bb0135","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.stemcr.2014.03.014","article-title":"Genetic and chemical correction of cholesterol accumulation and impaired autophagy in hepatic and neural cells derived from Niemann-Pick type C patient-specific iPS cells","volume":"2","author":"Maetzel","year":"2014","journal-title":"Stem Cell Reports."},{"key":"10.1016\/j.ymgme.2017.03.009_bb0140","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nbt1378","article-title":"Human embryonic stem cell derivation from poor-quality embryos","volume":"26","author":"Lerou","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymgme.2017.03.009_bb0145","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/ejhg.2013.214","article-title":"Two ABCB4 point mutations of strategic NBD-motifs do not prevent protein targeting to the plasma membrane but promote MDR3 dysfunction","volume":"22","author":"Degiorgio","year":"2014","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2017.03.009_bb0150","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nature06534","article-title":"Reprogramming of human somatic cells to pluripotency with defined factors","volume":"451","author":"Park","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2017.03.009_bb0155","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/ncb2566","article-title":"CDKL5 ensures excitatory synapse stability by reinforcing NGL-1-PSD95 interaction in the postsynaptic compartment and is impaired in patient iPSC-derived neurons","volume":"14","author":"Ricciardi","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymgme.2017.03.009_bb0160","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.nmd.2010.04.004","article-title":"Neutral lipid storage disease with subclinical myopathy due to a retrotransposal insertion in the PNPLA2 gene","volume":"10","author":"Akman","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2017.03.009_bb0165","doi-asserted-by":"crossref","first-page":"16644","DOI":"10.1074\/jbc.271.28.16644","article-title":"Acylglycerol recycling from triacylglycerol to phospholipid, not lipase activity, is defective in neutral lipid storage disease fibroblasts","volume":"271","author":"Igal","year":"1996","journal-title":"J. Biol. Chem."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719217300768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719217300768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T19:26:48Z","timestamp":1589743608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719217300768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1096719217300768"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2017.03.009","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of induced Pluripotent Stem Cells as disease modelling of NLSDM","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2017.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}